[Translation] A multicenter, randomized, double-blind, double-dummy, positive-drug parallel-controlled clinical study of crogancel nasal spray in the treatment of allergic rhinitis

评价色甘赛洛鼻喷雾剂治疗过敏性鼻炎的安全性和有效性。

[Translation]

To evaluate the safety and efficacy of cromoglucose nasal spray in the treatment of allergic rhinitis.

Start Date28 Mar 2008

Sponsor / Collaborator

Beijing Hua Xi Lianhe Tech & Development Ltd.

100 Clinical Results associated with Xylometazoline Hydrochloride/Sodium Cromoglicate

100 Translational Medicine associated with Xylometazoline Hydrochloride/Sodium Cromoglicate

100 Patents (Medical) associated with Xylometazoline Hydrochloride/Sodium Cromoglicate

Literatures (Medical) associated with Xylometazoline Hydrochloride/Sodium Cromoglicate

01 Jul 1987·The Journal of the Royal College of General Practitioners

Hay fever treatments--which should be tried first?

Article

Author: Tooley, M ; D'Souza, M F ; Charlton, J R

A series of comparative trials on nine popular and pharmacologically distinct regimens for the treatment of hay fever was undertaken in the course of normal general practice in the pollen seasons of 1981-83. One hundred and forty doctors recruited 640 patients to assess the overall usefulness of the treatments on daily diaries. ;Usefulness' was scored on a linear analogue scale weighing up the degree of hay fever symptoms during treatment, side effects and ease of use of the preparation.The regimen with the highest overall usefulness score was beclomethasone diproprionate with sodium cromoglycate eye drops (Beconase and Opticrom). Although the score was not significantly higher than those for methylprednisolone acetate (Depo-Medrone), astemizole (Hismanal) or terfenadine (Triludan), Beconase/Opticrom scored significantly better than mequitazine (Primalan), chlorpheniramine maleate (Piriton), sodium cromoglycate nasal insufflation with xylometazoline/antazoline eye drops (Rynacrom and Otrivine-Antistin) and azatadine maleate (Optimine). Beconase/Opticrom was first in rank order with respect to all the other regimens for the treatment of both mild and severe hay fever. Dimethothiazine (Banistyl), also shown to be useful, has since been withdrawn from prescription.

17 May 1985·South African medical journal = Suid-Afrikaanse tydskrif vir geneeskundeQ4 · MEDICINE

Sodium cromoglycate/chlorpheniramine and sodium cromoglycate nasal sprays in the treatment of seasonal rhinitis.

Q4 · MEDICINE

ArticleOA

Author: van Niekerk, C H

Fifty-one patients suffering from symptomatic seasonal rhinitis were studied in a double-blind comparative trial using nasal sprays containing 2% sodium cromoglycate (Rynacrom; Fisons) (group 1) or 2% sodium cromoglycate plus 0,2% chlorpheniramine (group 2). Dosage was two sprays into each nostril 4 times a day. There was a marked clinical improvement in both treatment groups although the differences between the two regimens were not significant. In group 2 80% of patients thought the treatment had been effective within 2 days and in group 1 58% of patients also experienced relief of symptoms within 2 days. At final assessment, full or reasonable control was achieved in 22 of 25 patients in group 2 and in 21 of 25 patients in group 1. These differences are not significant. Fourteen patients in group 2 and 6 patients in group 1 reported a burning sensation in the nose when the spray was administered, but this was usually mild and transient. No side-effects from the use of the intranasal antihistamine/sodium cromoglycate spray were recorded.

01 Nov 1982·Annals of allergy

The effects of disodium cromoglycate and beclomethasone dipropionate on the immediate response of the nasal mucosa to allergen challenge.

Article

Author: Pelikan, Z ; Pelikan-Filipek, M

This study deals with the comparative investigation of the protective effects of disodium cromoglycate (DSCG) Rynacrom, Intal and beclomethasone dipropionate aerosol (BDA); Aldecin Beconase on the immediate nasal mucosa response to allergen challenge due to the immediate hypersensitivity (Type I allergy) in 50 patients suffering from allergic rhinitis. DSCG demonstrated distinct protective effects on the immediate nasal mucosa response to allergen challenge in all patients investigated, while BDA failed to demonstrate any protective effects on the immediate nasal mucosa response to allergen challenge in any of the patients studied.

100 Deals associated with Xylometazoline Hydrochloride/Sodium Cromoglicate

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Rhinitis, Allergic	Phase 2	CN	-	28 Mar 2008

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

Xylometazoline Hydrochloride/Sodium Cromoglicate

Overview

Basic Info

Structure

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation